Molina Healthcare Aktie
| 293,42USD | -1,28USD | -0,43% |
WKN: 157781 / ISIN: US60855R1005
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 98,84 |
| The Vanguard Group, Inc. | 11,51 |
| Vanguard Group, Inc. (Subfiler) | 11,19 |
| Capital Research & Management Co. (World Investors) | 9,61 |
| Capital Research & Management Co. (World Investors) | 8,97 |
| T. Rowe Price Associates, Inc. (IM) | 6,89 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 6,74 |
| Capital Research & Management Co. (Global Investors) | 6,10 |
| Capital Research & Management Co. (Global Investors) | 6,10 |
| State Street Corp. | 4,57 |
| Wellington Management Co. LLP | 4,29 |
| BlackRock Fund Advisors | 3,90 |
| T. Rowe Price Investment Management, Inc. | 3,51 |
| American Funds Small Cap World Fund | 3,34 |
| Vanguard Total Stock Market ETF | 3,23 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 10 000 | 10 500 | 14 000 | 15 000 | 18 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,68 | 1,84 | 1,98 | 2,13 | 1,89 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 5 967 | 7 876 | 10 064 | 10 084 | 12 542 |
| Summe Anlagevermögen | 829 | 1 685 | 2 159 | 2 245 | 2 393 |
| Summe Aktiva | 6 796 | 9 561 | 12 223 | 12 329 | 14 935 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 4 836 | 7 465 | 9 593 | 9 365 | 10 720 |
| Summe Eigenkapital | 1 960 | 2 096 | 2 630 | 2 964 | 4 215 |
| Summe Passiva | 6 796 | 9 561 | 12 223 | 12 329 | 14 935 |
Adresse
| 200 Oceangate, 90802 Long Beach | |
| Telefon | +1 (562) 435-3666 |
| Internet | http://www.molinahealthcare.com |
Management
|
Amir Desai
Chief Information Officer |
|
Barbara L. Brasier
Independent Director |
|
Carolyn Ingram
Chief Marketing Officer |
|
Dale B. Wolf
Non-Executive Chairman |
|
Daniel Cooperman
Independent Director |
|
James E. Woys
Chief Operating Officer |
|
Jason Dees
Chief Medical Officer |
|
Jeff D. Barlow
Secretary & Chief Legal Officer |
|
Joseph Krocheski
Senior Vice President-Investor Relations |
|
Joseph M. Zubretsky
President, Chief Executive Officer & Director |
|
Lawrence D. Anderson
Chief Human Resources Officer |
|
Marc S. Russo
Executive Vice President-Medicaid Health Plan |
|
Mark L. Keim
Chief Financial Officer & Senior Executive VP |
|
Maurice S. Hebert
Chief Accounting Officer |
|
Richard C. Zoretic
Independent Director |
|
Richard M. Schapiro
Independent Director |
|
Ronald M. Kurtz
Chief of Staff |
|
Ronna E. Romney
Vice Chairman |
|
Stephen H. Lockhart
Independent Director |
|
Steve O'Dell
Senior VP-Growth & Corporate Development |
|
Steven J. Orlando
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
